Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predicting the molecular mechanism-driven progression of breast cancer through comprehensive network pharmacology and molecular docking approach.

Scientific reports - 22 Aug 2023

Vyas Bharti, Kumar Sunil, Bhowmik Ratul, Akhter Mymoona

Abstract excerpt

Identification of key regulators is a critical step toward discovering biomarker that participate in BC. A gene expression dataset of breast cancer patients was used to construct a network identifying key regulators in breast cancer. Overexpressed genes were identified with BioXpress, and then curated genes were used to construct the BC interactome network. As a result of selecting the genes with the highest...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Progression
Share to Drug Approval

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Repositioning

Share to Endometriosis

Share to Molecular Docking Simulation

Share to Reproducibility of Results

Share to United States

Share to United States Food and Drug Administration

Source

Open in PubMed Open full text

Identifiers

PMID: 37607964
DOI: 10.1038/s41598-023-40684-7
PMCID: PMC10444824

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predicting the molecular mechanism-driven progression of breast cancer through comprehensive network pharmacology and molecular docking approach.PMID 37607964Read ↗

A Network Pharmacology Study on the Molecular Mechanisms of FDY003 for Breast Cancer TreatmentSemantic proximity Read ↗

Exploring Drug-Target Interactions through Network Pharmacology in Breast cancer: A Text Mining ApproachSemantic proximity Read ↗

Transcriptomic analysis revealed potential regulatory biomarkers and repurposable drugs for breast cancer treatmentSemantic proximity Read ↗

Combinatorial analysis of gene regulatory network reveals the causal genetic basis of breast cancer and gene-specific personalized drug treatmentsSemantic proximity Read ↗

Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancerSemantic proximity Read ↗

Insights into Breast Cancer Prognosis: A Differential Regulatory Network Approach to Identify Key Transcription Factor BiomarkersSemantic proximity Read ↗

Nomogram Models Based on Gene Expression in Prediction of Breast Cancer Bone MetastasisSemantic proximity Read ↗

Network Pharmacology-Oriented Identification of Key Proteins and Signaling Pathways of breast cancerSemantic proximity Read ↗

Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.Semantic proximity Read ↗

Identification of Significant Genes and Therapeutic Agents for Breast Cancer by Integrated BioinformaticsSemantic proximity Read ↗

NPDI-BcCov: A Network Pharmacology Approach for Simultaneous Inference of Drugs Targeting Breast Cancer and COVID-19Semantic proximity Read ↗

Genome-wide screen identifies a novel prognostic signature for breast cancer survivalSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.